Chembio Diagnostics Operating Cycle 2011-2025 | CEMI

Annual Operating Cycle Chembio Diagnostics

2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
164	191	232	195	214	157	198	131	189	124	130	140

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
232	124	172

Quarterly Operating Cycle Chembio Diagnostics

2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
-	61.4	-	126	-	225	382	380	-	183	262	277	-	166	159	218	-	51.2	191	182	31.8	124	229	39.5	72.6	82.4	94.5	40.1	50	32.1	32.9	78.8	-	104	103	101	-	43.6	77.7	64.3	-	87.9	72.3	53.6	-	46.2	75.7	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
382	31.8	124

Operating Cycle of other stocks in the Diagnostics research industry

Issuer	Operating Cycle	Price	% 24h	Market Cap	Country
Centogene N.V. CNTG	170	-	-6.23 %	$ 30.6 M	Germany
Akumin AKU	57.4	-	-17.87 %	$ 25.9 M	Canada
Burning Rock Biotech Limited BNR	275	$ 15.82	0.44 %	$ 170 M	China
Accelerate Diagnostics AXDX	489	-	-61.36 %	$ 2.46 M	USA
Biocept BIOC	134	-	-13.05 %	$ 7.29 M	USA
BioNano Genomics BNGO	329	$ 1.55	-4.63 %	$ 1.97 M	USA
DarioHealth Corp. DRIO	251	$ 12.14	2.1 %	$ 344 M	Israel
DexCom DXCM	204	$ 65.83	-1.69 %	$ 25.4 B	USA
Castle Biosciences CSTL	97.9	$ 39.06	1.11 %	$ 1.08 B	USA
Exact Sciences Corporation EXAS	269	$ 101.64	0.14 %	$ 18.8 B	USA
Danaher Corporation DHR	150	$ 227.72	0.54 %	$ 166 B	USA
Fulgent Genetics FLGT	77.4	$ 27.0	-0.52 %	$ 816 M	USA
Global Cord Blood Corporation CO	202	-	-	$ 399 M	China
Genetic Technologies Limited GENE	11.8 K	-	-	$ 7.1 B	Australia
Genetron Holdings Limited GTH	185	-	0.12 %	$ 80.1 M	China
DermTech DMTK	114	-	-11.32 %	$ 2.94 M	USA
PRA Health Sciences, Inc. PRAH	1.22 K	-	-	$ 10.7 B	USA
CareDx, Inc CDNA	76.4	$ 19.98	-2.82 %	$ 1.07 B	USA
Enzo Biochem ENZ	206	-	-8.98 %	$ 14.8 K	USA
Anixa Biosciences ANIX	385	$ 3.3	-7.82 %	$ 105 K	USA
Co-Diagnostics CODX	405	$ 0.29	-14.47 %	$ 8.51 M	USA
IQVIA Holdings IQV	78	$ 222.75	0.24 %	$ 40.4 B	USA
Guardant Health GH	49.1	$ 103.7	1.6 %	$ 12.7 B	USA
Aspira Women's Health AWH	73.8	-	-6.19 %	$ 10.5 M	USA
Heska Corporation HSKA	177	-	-	$ 1.31 B	USA
HTG Molecular Diagnostics HTGM	216	-	-20.0 %	$ 1.06 M	USA
Illumina ILMN	198	$ 134.4	-0.35 %	$ 21.4 B	USA
Charles River Laboratories International CRL	67.7	$ 197.62	2.4 %	$ 10.2 B	USA
Quotient Limited QTNT	432	-	-11.32 %	$ 1.1 M	Schweiz
Mettler-Toledo International MTD	63.7	$ 1 410.02	1.15 %	$ 29.9 B	Schweiz
Quest Diagnostics Incorporated DGX	56.9	$ 183.96	0.79 %	$ 20.4 B	USA
NeoGenomics NEO	103	$ 12.03	1.48 %	$ 1.52 B	USA
Neogen Corporation NEOG	213	$ 6.85	-0.22 %	$ 1.49 B	USA
Biodesix BDSX	41.7	$ 7.63	-2.8 %	$ 989 M	USA
Myriad Genetics MYGN	87.1	$ 7.04	-2.36 %	$ 638 M	USA
Laboratory Corporation of America Holdings LH	72.9	$ 262.89	-0.48 %	$ 22.1 B	USA
ICON Public Limited Company ICLR	68.5	$ 184.38	-1.18 %	$ 15.2 B	Irlanda
IDEXX Laboratories IDXX	135	$ 698.77	-0.77 %	$ 57.6 B	USA
Lantheus Holdings LNTH	116	$ 66.4	-0.33 %	$ 4.59 B	USA
Agilent Technologies A	161	$ 140.3	0.46 %	$ 42.7 B	USA
Biomerica BMRA	204	$ 2.48	-2.65 %	$ 5.7 M	USA
Bioventus BVS	267	$ 7.49	-0.86 %	$ 469 M	USA
Pacific Biosciences of California PACB	183	$ 2.13	0.24 %	$ 540 M	USA
Motus GI Holdings MOTS	3.45 K	-	-34.28 %	$ 263 K	Israel